CS Professional · Strategic Management and Corporate Finance · Sources of Corporate Funding
Which feature chiefly distinguishes a convertible note or compulsorily convertible preference share used in start-up funding from plain equity at the time of investment?
Convertible instruments let the investor and founders postpone or formula-fix the valuation until a later event, and preference-type instruments give a preferential claim before conversion into equity. They are not permanent debt, do not require listing, and do not give control without shareholding.
- AIt carries no possibility of ever becoming equity
- BIt allows the investor to defer fixing the final valuation or to receive a preferential claim before converting into equityCorrect
- CIt requires the start-up to list on a stock exchange immediately
- DIt gives the investor management control without any shareholding
Explanation
Convertible instruments convert into equity later, on a trigger or at a pre-agreed formula, so valuation can be settled at a later round, and preference shares rank ahead of equity for dividend and capital. They do convert to equity, need no listing and do not give control without shareholding.
Did you get it right without looking?
One question tells you little. A timed set on Sources of Corporate Funding shows your real accuracy, how long you take and where you lose marks.
More Sources of Corporate Funding questions
- Under the Companies Act, 2013, which statement about preference shares issued by an unlisted public company is correct?
- Sunrise Textiles Ltd raised a term loan of Rs 60,00,000 repayable in 5 equal annual instalments of principal at the end of each year, with i…
- A company has equity share capital of Rs 60 lakh with cost of equity 15% and 10% debentures of Rs 40 lakh. The tax rate is 25%. What is its …
- Meridian Finance pools ₹200 crore of vehicle loans and transfers them to a special purpose vehicle (SPV), which issues pass-through certific…
- Sundaram Auto Ltd issues 10,000 convertible debentures of Rs 1,000 each. Each debenture is convertible into 20 equity shares. The current ma…
- Vihaan Pharma Ltd has 20 lakh equity shares of Rs 10 each, fully paid. It makes a rights issue of 1 share for every 4 held at Rs 120 per sha…